Trial Profile
An analytical study of laboratory tests and clinical effectiveness for combination therapies using GnRH antagonist/antiandrogen and GnRH aonist/antiandrogen in prostate cancer patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2014
Price :
$35
*
At a glance
- Drugs Degarelix (Primary) ; Bicalutamide; LHRH receptor agonists
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 Mar 2014 New trial record